Aliases & Classifications for Peripheral Vertigo

Aliases & Descriptions for Peripheral Vertigo:

Name: Peripheral Vertigo 12 14
Vertigo, Peripheral 69

Classifications:



External Ids:

Disease Ontology 12 DOID:9847
ICD9CM 35 386.1 386.19
UMLS 69 C0029706

Summaries for Peripheral Vertigo

MalaCards based summary : Peripheral Vertigo, also known as vertigo, peripheral, is related to acute infection of pinna and med13l syndrome, and has symptoms including vertigo An important gene associated with Peripheral Vertigo is CRP (C-Reactive Protein), and among its related pathways/superpathways are Collagen chain trimerization and Formation of Fibrin Clot (Clotting Cascade). The drugs Dexamethasone and Epinephrine have been mentioned in the context of this disorder. Affiliated tissues include neutrophil, and related phenotypes are homeostasis/metabolism and mortality/aging

Related Diseases for Peripheral Vertigo

Diseases related to Peripheral Vertigo via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 136)
id Related Disease Score Top Affiliating Genes
1 acute infection of pinna 10.3 CRP F2
2 med13l syndrome 10.3 APOH F5
3 stt3a-cdg and stt3b-cdg 10.3 F5 SERPINC1
4 sertoli cell tumor 10.3 F3 SERPINC1
5 acro coxo mesomelic dysplasia 10.3 CRP F5
6 hereditary endotheliopathy, retinopathy, nephropathy, and stroke 10.3 F3 SERPINC1
7 acrodysplasia with ossification abnormalities, short stature and fibular hypoplasia 10.3 F3 F5
8 achard thiers syndrome 10.3 APOH F5
9 hemarthrosis 10.3 F2 F3
10 congenital insensitivity to pain with severe intellectual disability 10.3 F2 F5
11 acrodysplasia scoliosis 10.3 F3 F5
12 miller-dieker lissencephaly syndrome 10.3 F2 SERPINC1
13 alpha-2-macroglobulin deficiency 10.3 F2 F3
14 citrulline transport defect 10.3 CRP F2
15 lung cancer 10.3 APOH F5
16 cataract 10.3 CRP SERPINC1
17 synostosis 10.3 CRP F2
18 mixed epithelial tumor of ovary 10.3 F2 SERPINC1
19 oxyphilic adenoma 10.3 F2 F5
20 secretory diarrhea myopathy and deafness 10.3 CRP F3 SERPINC1
21 prostatic hypertrophy 10.3 F2 F3
22 lupus erythematosus 10.3 CRP F3 SERPINC1
23 dyskinetic cerebral palsy 10.2 F2 F3
24 peanut allergy 10.2 F2 SERPINC1
25 landau-kleffner syndrome 10.2 APOH F2
26 parapharyngeal meningioma 10.2 CRP F5
27 influenza 10.2 F2 F3 SERPINC1
28 freiberg's disease 10.2 F2 F3 SERPINC1
29 chorioretinal scar 10.2 F2 F3 SERPINC1
30 artery disease 10.2 CRP F2 F3
31 mixed hepatoblastoma 10.2 F2 F3 SERPINC1
32 central congenital hypothyroidism 10.2 APOH F3 F5
33 dmd-related dilated cardiomyopathy 10.2 F2 F3 SERPINC1
34 ductal carcinoma in situ 10.2 F2 F3 SERPINC1
35 essential thrombocythemia 10.2 F2 F3 SERPINC1
36 stroke, ischemic 10.2 F2 F3 F5
37 epstein-barr virus hepatitis 10.2 F2 F3 SERPINC1
38 houlston ironton temple syndrome 10.2 CRP F2 F5
39 fletcher factor deficiency 10.2 F2 F3 F5
40 czech dysplasia 10.2 APOH F5 SERPINC1
41 villous adenoma 10.2 CRP F2 F5
42 myotonic dystrophy 10.2 F2 F3 F5
43 hereditary alpha tryptasemia syndrome 10.2 F2 F3 SERPINC1
44 scapuloperoneal myopathy, x-linked dominant 10.2 F2 F3 SERPINC1
45 myosclerosis, congenital 10.2 F5 SERPINC1
46 capillary hemangioma 10.2 F2 F3 SERPINC1
47 neuroaxonal dystrophy 10.2 F2 F5 SERPINC1
48 hennekam lymphangiectasia-lymphedema syndrome 2 10.2 F2 F3 SERPINC1
49 hemolytic-uremic syndrome 10.2 F2 F3 SERPINC1
50 pyelonephritis 10.2 CRP F2 SERPINC1

Comorbidity relations with Peripheral Vertigo via Phenotypic Disease Network (PDN):


Hypertension, Essential Ischemic Heart Disease
Labyrinthitis

Graphical network of the top 20 diseases related to Peripheral Vertigo:



Diseases related to Peripheral Vertigo

Symptoms & Phenotypes for Peripheral Vertigo

UMLS symptoms related to Peripheral Vertigo:


vertigo

MGI Mouse Phenotypes related to Peripheral Vertigo:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.7 AQP2 AQP5 AVP CRP F2 F3
2 mortality/aging MP:0010768 9.32 APOH AQP2 AQP5 AVP CRLF1 F2

Drugs & Therapeutics for Peripheral Vertigo

Drugs for Peripheral Vertigo (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 295)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3 50-02-2 5743
2
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
3
Histamine Approved, Investigational Phase 4,Phase 3 75614-87-8, 51-45-6 774
4
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
5
Ondansetron Approved Phase 4,Phase 2 99614-02-5 4595
6
Amitriptyline Approved Phase 4,Phase 1 50-48-6 2160
7
Bupivacaine Approved, Investigational Phase 4,Phase 1,Phase 2 2180-92-9, 38396-39-3 2474
8
Ketamine Approved, Vet_approved Phase 4,Phase 1,Phase 2 6740-88-1 3821
9
Tramadol Approved, Investigational Phase 4,Phase 2,Phase 1 27203-92-5 33741
10
Hydromorphone Approved, Illicit Phase 4,Phase 2 466-99-9 5284570
11
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2 148553-50-8 5486971
12
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
13
Cyclobenzaprine Approved Phase 4 303-53-7 2895
14
Norepinephrine Approved Phase 4,Phase 1 51-41-2 439260
15
Dopamine Approved Phase 4,Phase 3 51-61-6, 62-31-7 681
16
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 60142-96-3 3446
17
Morphine Approved, Investigational Phase 4,Phase 3,Phase 1 57-27-2 5288826
18
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
19
Ibuprofen Approved Phase 4,Phase 3,Phase 2 15687-27-1 3672
20
Galantamine Approved Phase 4,Phase 2 357-70-0 9651 908828, 9651
21 Piracetam Approved Phase 4 7491-74-9
22
Metoclopramide Approved, Investigational Phase 4 364-62-5 4168
23
Haloperidol Approved Phase 4 52-86-8 3559
24
Ephedrine Approved Phase 4,Phase 2,Phase 3 299-42-3 9294
25
Midodrine Approved Phase 4,Phase 2 133163-28-7, 42794-76-3 4195
26
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
27
Remifentanil Approved Phase 4 132875-61-7 60815
28
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
29
Chlorzoxazone Approved Phase 4 95-25-0 2733
30
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
31
Flunarizine Approved Phase 4 52468-60-7 941361
32
Modafinil Approved, Investigational Phase 4 68693-11-8 4236
33
Pseudoephedrine Approved Phase 4,Phase 2,Phase 3 90-82-4 7028
34
Dimenhydrinate Approved Phase 4,Phase 3 523-87-5 441281
35
Ropivacaine Approved Phase 4,Phase 2 84057-95-4 71273 175805
36
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 437-38-7 3345
37
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
38
Nicergoline Approved Phase 4 27848-84-6 34040
39
Armodafinil Approved, Investigational Phase 4 112111-43-0
40 Ramosetron Approved Phase 4 132036-88-5
41
Chlorpromazine Approved, Vet_approved Phase 4 50-53-3 2726
42
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
43
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
44
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
45
Ipratropium Approved Phase 4 22254-24-6, 60205-81-4 43232
46
Hydrocodone Approved, Illicit Phase 4 125-29-1 5284569
47
Bisoprolol Approved Phase 4 66722-44-9 2405
48
Niacin Approved, Investigational, Nutraceutical Phase 4 59-67-6 938
49
Nicotinamide Approved, Nutraceutical Phase 4 98-92-0 936
50
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 1 59-30-3 6037

Interventional clinical trials:

(show top 50) (show all 162)
id Name Status NCT ID Phase
1 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4
2 Cyclobenzaprine Extended Release (ER) for Fibromyalgia Unknown status NCT01041495 Phase 4
3 Randomized Study of Pregabalin for Pain Reduction in Patients With Rest Pain and Lower Limb Ischemia Unknown status NCT00403780 Phase 4
4 Preventing Pain After Heart Surgery Unknown status NCT01480765 Phase 4
5 Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo Completed NCT01890538 Phase 4
6 Impact of Cardiac Magnetic Resonance Imaging on Endothelial Function in Type 2 Diabetes Completed NCT02001753 Phase 4
7 An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue Completed NCT00678691 Phase 4
8 The Analgesic Effect of Combined Nerve Block and Systemic High Dose Glucocorticoid After Total Knee Arthroplasty. Completed NCT02374008 Phase 4
9 Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo Completed NCT02253524 Phase 4
10 Effect of Stellate Ganglion Block on Meniere's Disease Completed NCT01574313 Phase 4
11 A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Gastroenteritis Completed NCT00124787 Phase 4
12 Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol Completed NCT00740259 Phase 4
13 Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients After Hip Operations Completed NCT00235261 Phase 4
14 Effect of Paracetamol,Pregabalin and Dexamethasone on Pain and Opioid Requirements in Postoperative Patients Completed NCT00209495 Phase 4
15 Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine Completed NCT01009476 Phase 4
16 Perioperative Administration of Pregabalin for Pain After Mastectomy Completed NCT00938548 Phase 4
17 Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery Completed NCT02478645 Phase 4
18 A Study for Patients With Neurogenic Orthostatic Hypotension Completed NCT00046475 Phase 4
19 Ibuprofen vs Acetaminophen for AMS Prevention Completed NCT02244437 Phase 4
20 Low Doses of Ketamine and Postoperative Quality of Recovery Completed NCT02571153 Phase 4
21 Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour Completed NCT00202722 Phase 4
22 Opioid-induced Hyperalgesia After Remifentanil Infusion Completed NCT01702389 Phase 4
23 Perioperative Administration of Pregabalin for Pain After Robot-assisted Endoscopic Thyroidectomy Completed NCT00905580 Phase 4
24 A Prospective Randomized Double-Blind Trial Comparing 3 Doses of Intravenous Ketorolac for Pain Management Completed NCT02078492 Phase 4
25 Prophylactic Ephedrine and Combined Spinal Epidurals for Labor Completed NCT02062801 Phase 4
26 IV Acetaminophen as an Adjunct Analgesic in Cardiac Surgery Completed NCT01544062 Phase 4
27 The Effect of Anti-inflammatory Analgesics on Pain Following Hallux Valgus Surgery Completed NCT00733421 Phase 4
28 Sole Local Anesthetic Versus Opioid Plus Local Anesthesia in Epidural Labor Analgesia Completed NCT02036242 Phase 4
29 The Role of Gabapentin in Postoperative Pain and Epithelialization After Photorefractive Keratectomy Completed NCT01177514 Phase 4
30 The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery Completed NCT01933542 Phase 4
31 Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features Recruiting NCT00202293 Phase 4
32 Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD Recruiting NCT02576626 Phase 4
33 Intraperitoneal Dexmedetomidine for Post-laparoscopic Appendicectomy Pain Management in Children Recruiting NCT03067740 Phase 4
34 Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function Recruiting NCT02379754 Phase 4
35 Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function Recruiting NCT02415257 Phase 4
36 Acute Unilateral Vestibulopathy and Corticosteroid Treatment Recruiting NCT02912182 Phase 4
37 DEXRAR: DEXamethasone in Revision ARthroplasty Recruiting NCT02884180 Phase 4
38 Lidocaine vs Ketorolac for Renal Colic Recruiting NCT03137498 Phase 4
39 Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery Active, not recruiting NCT02535000 Phase 4
40 Ketamine: Comparison of IV Push vs. IV Drip Active, not recruiting NCT02363270 Phase 4
41 Ice T Postoperative Multimodal Pain Regimen in FPMRS Surgery Active, not recruiting NCT03052816 Phase 4
42 Effect of Ivabradine and Beta-blockers Combination Versus Beta-blockers Up-titration on Right Ventricular Pacing Suspended NCT01868880 Phase 4
43 The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery Terminated NCT00236223 Phase 4
44 A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension Terminated NCT00046163 Phase 4
45 Comparison of Monitored Anesthesia Care Using Remifentanil or Fentanyl for Major Dressing Changes in Burns Terminated NCT00326859 Phase 4
46 Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients Having a Tonsillectomy Terminated NCT00378547 Phase 4
47 The Efficacy of Steroid Therapy in Vestibular Neuritis Unknown status NCT02098330 Phase 3
48 Promethazine vs. Lorazepam for Treatment of Vertigo Completed NCT01827293 Phase 3
49 Conventional Versus Virtual Reality Based Vestibular Rehabilitation Completed NCT01442623 Phase 2, Phase 3
50 Postoperative Pain and Morphine Consumption After Mastectomy - Lyrica Completed NCT01391858 Phase 3

Search NIH Clinical Center for Peripheral Vertigo

Genetic Tests for Peripheral Vertigo

Anatomical Context for Peripheral Vertigo

MalaCards organs/tissues related to Peripheral Vertigo:

39
Neutrophil

Publications for Peripheral Vertigo

Articles related to Peripheral Vertigo:

(show all 40)
id Title Authors Year
1
Clinical Reasoning: Labyrinthine hemorrhage: An unusual etiology for peripheral vertigo. ( 28069982 )
2017
2
Effect of a vestibular rehabilitation protocol to improve the health-related quality of life and postural balance in patients with peripheral vertigo. ( 27676762 )
2016
3
THE USEFULNESS OF MONITORING THE NEUTROPHIL TO LYMPHOCYTE RATIO IN PATIENTS WITH PERIPHERAL VERTIGO. ( 27661276 )
2016
4
Use of betahistine in the treatment of peripheral vertigo. ( 26245698 )
2015
5
Associations between peripheral vertigo and gastroesophageal reflux disease. ( 26115947 )
2015
6
Anxiety and depression among patients with different types of vestibular peripheral vertigo. ( 25654382 )
2015
7
Outcomes among patients discharged from the emergency department with a diagnosis of peripheral vertigo. ( 26385410 )
2015
8
Histamine Antagonists for Treatment of Peripheral Vertigo: A Meta-Analysis. ( 26381004 )
2015
9
Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo in the emergency department: A double blind, randomized clinical trial of efficacy and safety. ( 24594499 )
2014
10
Neutrophil-to-lymphocyte ratio in patients with peripheral vertigo: A prospective controlled clinical study. ( 25219290 )
2014
11
Response to: "Cerebellar infarctions mimicking acute peripheral vertigo," from Yeo et al. ( 23633501 )
2013
12
Evaluation of the effect of nimodipine o.d. (extended release) vs nimodipine t.i.d. in the treatment of peripheral vertigo. ( 23808594 )
2013
13
Letter to the editor on "Cerebellar infarctions mimicking acute peripheral vertigo: how to avoid misdiagnosis?". ( 23633500 )
2013
14
Comparison of the effectiveness of intravenous piracetam and intravenous dimenhydrinate in the treatment of acute peripheral vertigo in the emergency department. ( 24276103 )
2013
15
Cerebellar infarctions mimicking acute peripheral vertigo: how to avoid misdiagnosis? ( 23307911 )
2013
16
An easy diagnostic tool distinguishing lateral medullary infarction from peripheral vertigo. ( 21855212 )
2012
17
Medullary infarction after vertebral artery dissection presenting as acute peripheral vertigo. ( 21307810 )
2011
18
Sonographic examination of epiaortic vessels in patients with peripheral vertigo. ( 23396499 )
2010
19
Is surgical vestibular ablation necessary in disabling peripheral vertigo? ( 23120494 )
2008
20
Stiff-person syndrome with acute recurrent peripheral vertigo: possible evidence of gamma aminobutyric acid as a neurotransmitter in the vestibular periphery. ( 17666138 )
2008
21
Role of C-reactive protein, D-dimer, and fibrinogen levels in the differential diagnosis of central and peripheral vertigo. ( 18029334 )
2007
22
Intracranial vertebral artery dissection mimicking acute peripheral vertigo. ( 16428195 )
2006
23
Surgical treatment of peripheral vertigo and vertiginous diseases. ( 15637415 )
2005
24
Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo. ( 15474112 )
2004
25
Acute peripheral vertigo: involvement of the hemostatic system. ( 15106288 )
2003
26
Relevance of plasma D-dimer measurement in patients with acute peripheral vertigo. ( 12818056 )
2003
27
Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial. ( 12045085 )
2002
28
A study on peripheral vertigo in a Kolkata based hospital. ( 23119868 )
2002
29
New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study. ( 11981396 )
2002
30
Posterior fossa vestibular nerve section for the management of peripheral vertigo. ( 10392296 )
1999
31
Droperidol for the treatment of acute peripheral vertigo. ( 9928721 )
1999
32
3D analysis of nystagmus in peripheral vertigo. ( 9105433 )
1997
33
Surgical treatment of incapacitating peripheral vertigo. Criteria for the evaluation of surgical results. ( 8022609 )
1994
34
Overall view and rationale for surgical alternatives for incapacitating peripheral vertigo. ( 8022608 )
1994
35
Transdermal scopolamine for peripheral vertigo (a double-blind study). ( 3894551 )
1985
36
Peripheral vertigo. ( 3979333 )
1985
37
Complications of treatment of peripheral vertigo. ( 6149924 )
1984
38
Peripheral vertigo. ( 6499706 )
1984
39
The causes of peripheral vertigo. ( 6499708 )
1984
40
Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo. ( 7019369 )
1981

Variations for Peripheral Vertigo

Expression for Peripheral Vertigo

Search GEO for disease gene expression data for Peripheral Vertigo.

Pathways for Peripheral Vertigo

GO Terms for Peripheral Vertigo

Cellular components related to Peripheral Vertigo according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.76 APOH AQP2 AQP5 COCH CRP F2
2 extracellular region GO:0005576 9.61 APOH AVP COCH CRLF1 CRP F2
3 extracellular space GO:0005615 9.23 APOH AVP CRLF1 CRP F2 F3

Biological processes related to Peripheral Vertigo according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 blood coagulation GO:0007596 9.56 F2 F3 F5 SERPINC1
2 blood coagulation, intrinsic pathway GO:0007597 9.4 APOH F2
3 positive regulation of blood coagulation GO:0030194 9.37 APOH F2
4 regulation of blood coagulation GO:0030193 9.33 APOH F2 SERPINC1
5 negative regulation of fibrinolysis GO:0051918 9.32 APOH F2
6 water transport GO:0006833 9.13 AQP2 AQP5 AVP
7 hemostasis GO:0007599 8.92 F2 F3 F5 SERPINC1

Molecular functions related to Peripheral Vertigo according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 heparin binding GO:0008201 9.13 APOH F2 SERPINC1
2 water channel activity GO:0015250 8.62 AQP2 AQP5

Sources for Peripheral Vertigo

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....